D-0330-2015 Class II Terminated

Recalled by Aurobindo Pharma USA Inc — Dayton, NJ

FDA drug recall D-0330-2015 was initiated by Aurobindo Pharma USA Inc on Oct 17, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Complaints of empty capsules received. The recall status is terminated (terminated May 23, 2016). Affected quantity: 24,816 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 14, 2015
Initiation Date
Oct 17, 2014
Termination Date
May 23, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,816 bottles

Product description

Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.

Reason for recall

Failed Tablet/Capsule Specifications: Complaints of empty capsules received.

Distribution pattern

Nationwide

Code information

Lot #: GESB14011-A, Exp 12/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0330-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0330-2015. Report a data issue: hello@regdatalab.com.